Breaking News on Contract Research, Manufacturing & Clinical Trials

Cambrex: delayed API plant opening set for Q2 opening

02-May-2016 - An API facility Cambrex is setting up in Charles City, Iowa will be operational later than planned due to delayed equipment deliveries and installation challenges.

French regulators lift manufacturing ban at Catalent softgel plant

02-May-2016 - Full production at Catalent’s Beinheim softgel plant has begun five months after the discovery of out-of-place capsules led to French regulators suspending operations.

Manufacturers concede on price as drug spending increases

02-May-2016 - Specialty medicine innovation is driving growth, yet advances are being offset by price concessions from manufacturers, according to IMS Health.

Aptar launches sensor counter tech for MDIs

28-Apr-2016 - Aptar Pharma has launched a new counter technology for metered dose inhalers (MDIs) it says can help enhance patient adherence.

Wuxi sets up drug supplier network to ease pharma sourcing

27-Apr-2016 - WuxI AppTec has a chemical trading network designed to help drug manufacturers source more efficiently.

Lonza to invest in existing mammalian cell culture facilities after strong Q1

27-Apr-2016 - Lonza plans to expand mammalian cell culture-based drug and viral manufacturing capacity after growth in both businesses helped it to record first quarter sales.

Controlled substances: fewer CMOs, more regulations

26-Apr-2016 - The manufacture of controlled substances has faced increased scrutiny over the years, and as such, fewer CMOs are in the market.

Almac Group launches new serialization solution

26-Apr-2016 - Almac Group has expanded its serialization capabilities to include its US commercial packaging facility in Audubon, PA.

Innova Biosciences relocates commercial team and preps for lab expansion

25-Apr-2016 - Bioconjugation services firm Innova Biosciences has relocated its UK sales and marketing operations citing growing pharmaceutical industry demand.

BARDA talks medical countermeasure manufacturing

25-Apr-2016 - This year at Interphex, BARDA will discuss various strategies and innovations to reduce drug shortages and improve medicines availability.

GSK's Ware Ellipta plant to supply US after Zebulon line operational

25-Apr-2016 - GSK has confirmed its new UK plant will continue to supply the US with Ellipta inhalers after capacity at its facility in North Carolina comes online this year.

WHO removes TB and malaria drug APIs made by Anuh Pharma from approved list

21-Apr-2016 - The WHO has removed two APIs supplied by Anuh Pharma from its list of prequalified ingredients and announced plans to inspect the firm’s facility in Boisar, India.

'It was time' for dedicated polymer group, says PCI CEO

21-Apr-2016 - PCI Synthesis has formed a cGMP Advanced Polymer Development and Manufacturing Group after experiencing a growing demand from the industry.

PCI Synthesis sets up polymers development lab

20-Apr-2016 - API manufacturer PCI Synthesis has set up a polymer development group citing growing drug industry demand for advanced coating technologies and excipient technologies.

Recipharm to buy Kemwell's API and formulations business for SEK1.7bn

18-Apr-2016 - Recipharm has agreed to buy Kemwell’s contract development and manufacturing business for a total of SEK1.7bn in two separate deals.

Famar set to step into North America by buying Quebec plant from Bayer

18-Apr-2016 - European CDMO Famar says it will continue making products on behalf of Bayer after acquiring a Canadian manufacturing facility from the firm.

Lonza would add drug delivery tech through Catalent merger, analyst

14-Apr-2016 - Lonza acquiring Catalent would make “strategic sense,” according to an analyst as rumours circulate about a CMO megamerger.

Colorcon launches new coating for multiparticulate pills

13-Apr-2016 - Colorcon has launched a tablet coating system for multiparticulate dosage forms citing growing demand for such pills, particularly among the elderly.

WellSpring Pharma completes $3m investment, $10m partnership

13-Apr-2016 - WellSpring Pharma Services has announced a $3 million capital investment in new equipment in addition to a new strategic partnership with IDT Australia to manufacture drugs targeting the US market.

Quotient invests in spray drying tech in response to demand

12-Apr-2016 - Quotient Clinical has expanded spray drying capacity at its facility in Nottingham, UK citing growing industry interest in solubility enhancement.

News in brief

Orchid Pharma antibiotic API plant passes US FDA inspection

11-Apr-2016 - API firm Orchid Pharma has passed a US Food and Drug Administration (FDA) inspection at its facility in Tamil Nadu, India.

Recipharm completes acquisition of majority stake in Nitin Lifesciences

11-Apr-2016 - Recipharm has completed the acquisition of a majority stake in India’s Nitin Lifesciences in a deal the Swedish contractor says strengthens its presence in an important market.

Gilead antiviral API supplier expanding plant after US FDA OKs Descovy

07-Apr-2016 - Pharmachem Technologies has started expanding its API facility in Grand Bahama just days after its main customer Gilead Sciences won US FDA approval for a new HIV drug.

Dispatches from DCAT Week

'Chindia' drug substance market not to be discounted

06-Apr-2016 - China and India are causing a “tsunami” in the drug substance market – yet significant hurdles may bring fine chemical outsourcing back to the West.

Supply chain fraud continues to plague companies, poll says

05-Apr-2016 - For the third year in a row, about 30% of Deloitte poll respondents say their companies experienced supply chain fraud, waste, or abuse in the previous year. 

Key Industry Events


Access all events listing

Our events, Shows & Conferences...